期刊文献+

急性心肌梗死患者PCI后BNP、hsCRP、cTnI的预后意义 被引量:9

Prognostic significance of levels of BNP,hsCRP and cTnI in patients with acute myocardial infarction after PCI
下载PDF
导出
摘要 目的:观察急性心肌梗死(AMI)患者经皮冠状动脉成形术(PCI)后脑钠肽(BNP)、高敏C反应蛋白(hsCRP)、心肌肌钙蛋白I(cTnI)水平的预后意义。方法:入选90例行PCI的AMI患者,于PCI后1d、7d测定血浆中BNP、hsCRP、cTnI水平,随访6个月内的主要心脏不良事件(MACE),并与AMI药物治疗患者(45例,药物治疗组),健康体检者(30例,健康对照组)进行对比分析。结果:术后1d,与健康对照组比较,AMI两组患者hsCRP、BNP、cTnI水平均明显升高(P均<0.01),但PCI组和药物治疗组比较无显著差异(P>0.05)。术后7d,与药物治疗组比较,PCI组hsCRP[(13.5±3.3)mg/L比(7.5±0.3)mg/L]、BNP[(2036±135)ng/L比(336±27)ng/L]、cTnI[(7.3±0.3)ng/L比(2.3±0.3)ng/L]水平明显降低(P<0.01),PCI组MACE发生率明显低于药物治疗组(27.8%比46.7%),P<0.01。结论:急诊PCI治疗优于药物治疗,联合检测脑钠肽、高敏C反应蛋白和心肌肌钙蛋白I水平有助于判断急性心肌梗死行PCI患者的预后。 Objective:To observe prognostic significance of levels of brain natriuretic peptide(BNP),high sensitive C reactive protein(hsCRP)and cardiac troponin I(cTnI)in patients with acute myocardial infarction(AMI)after percutaneous coronary intervention(PCI).Methods:A total of 90AMI patients undergoing PCI were enrolled,plasma levels of BNP,hsCRP and cTnI were measured after PCI 1dand 7d,and major adverse cardiovascular events(MACE) within six months were followed up.They were compared and analyzed with those of AMI medication patients(n=45,medication group) and healthy subjects(n=30,healthy control group).Results:Compared with healthy control group after PCI 1d,there were significant increase in levels of hsCRP,BNP and cTnI in two AMI groups(P〈0.01all),but there were no significant difference between PCI group and medication group,P〈0.01.Compared with medication group after PCI 7d,there were significant decrease in levels of hsCRP [(13.5±3.3) mg/L vs.(7.5±0.3) mg/L ],BNP [(2036±135) ng/L vs.(336±27) ng/L ] and cTnI [(7.3±0.3) ng/L vs.(2.3± 0.3) ng/L ] in PCI group,P〈0.01all.Compared with medication group after PCI six-month,there was significant decrease in incidence rate of MACE(46.7%vs.27.8%) in PCI group,P〈0.01.Conclusion:Emergency PCI is superior to medication.Combined detection of levels of BNP,hsCRP and cTnI contributes to judge prognosis in AMI patients undergoing PCI.
出处 《心血管康复医学杂志》 CAS 2013年第3期227-230,共4页 Chinese Journal of Cardiovascular Rehabilitation Medicine
关键词 心肌梗塞 血管成形术 经腔 经皮冠状动脉 利钠肽 C反应蛋白质 Myocardial infarction Angioplasty transluminal percutaneous coronary Natriuretic peptide brain C-reactive protein
  • 相关文献

参考文献11

  • 1Daniels LB, Maisel AS. Natriuretic peptides [J]. J Am Coll Cardial, 2007, 50 (25): 2357-2368.
  • 2Morita E, Yasue H, Yoshimura M, et al. Increased plasma levels of brain natriuretic peptide in patients with acute myocardial infarction [J]. Circulation, 1993, 88 (1) : 82-91.
  • 3Arakawa N, Nakamura M, Aoki H, et al. Relationship between plasma level of brain natriuretic peptide and myocardial infarct size [J]. Cardiology, 1994, 85 (5): 334-340.
  • 4Jeng WK, Jeng MH, Kim KH, et al. An elevated value of C- reactive protein is the only predictive factor of restenosis after pereutaneous coronary intervention [J]. Korean J Intern Med, 2003, 18 (3): 154-160.
  • 5刘蓉,杨跃进,乔树宾,陈纪林,陈在嘉,高润霖,吴元,杨伟宪,赵冬云.高敏C反应蛋白对急性ST段抬高型心肌梗死患者近期预后的预测价值[J].中国循环杂志,2011,26(1):19-22. 被引量:70
  • 6罗巍,丁家崇,周海依.急性冠脉综合征行急诊PCI术后hs-CRP和NT-proBNP的临床意义及其预测价值[J].心脏杂志,2012,24(1):63-66. 被引量:10
  • 7Verma S,Wang CH,Weisel RD,et al. Hyperglycemia potentiates the proatherogenic effects of C-reactive protein: reversal with rosiglitazone[J]. J Mol Cell Cardiol, 2003, 35(4):417-419.
  • 8Kelsall CJ, Chester AH, Sarathchandra P, et al. Expression and localization of C-type natriuretic peptide in human vascular smooth muscle cells [J]. Vascular Pharmacol, 2006, 45 (6): 368-373.
  • 9赵全明.最新心肌梗死定义解读[J].中华临床医师杂志(电子版),2008,2(11):46-48. 被引量:6
  • 10Apple FS, Jesse RL, Newby LK, et al. National Academy of Clinical Biochemistry and IFCC Committee for Standardization of Markers of Cardiac Damage Laboratory Medicine Practice Guide lines: analytical issues for biochemical markers of acute coronary syndromes [J].Clin Chem, 2007, 53 (4): 547-551.

二级参考文献30

  • 1何奔,丁嵩,卜军,刘建平,宋玮,杜勇平,沈节艳,金叔宣,孙瑜,沈珑.脑利钠肽和C-反应蛋白在急性冠状动脉综合征介入治疗患者的预后价值[J].中华心血管病杂志,2006,34(4):349-352. 被引量:56
  • 2井娜,孙海宁,车至香.心肌损伤标志物与心力衰竭[J].心血管康复医学杂志,2007,16(1):101-102. 被引量:9
  • 3Antman EM, Tanasijevic MJ, Thompson B, et al. Cardiacspecific troponin Ⅰ levels to predict the risk of mortality in patients with acute coronary syndromes [J]. Nengl J Med, 2006, 335: 1342-1349.
  • 4Boberts R, Fromm RE. Management of acute coronary syndromes based on risk stratification by biochemical markers in idea whose time has come [J]. Circulation, 2004, 98: 1831- 1833.
  • 5Etievent JP, Choeron S, Toubin G, et al. Use of cTnI as a marker of perioperative myocardial isehemia [J]. Ann Thorac Sung, 2006, 59: 1192-1195.
  • 6Libby P, Ridker PM, Maseri A. Inflammation and atherosclerosis. Circulation ,2002,105 : 1135-1143.
  • 7Mendall MA, Strachan DP, Butland BK, et al. C-reactive protein: relation to total mortality, cardiovascular mortality and cardiovascular risk factors in men. Eur Heart J,2000,21:1584-1590.
  • 8Schnabel R, Rupprecht HJ, Lackner KJ, et al. Analysis of N-terminal-pro-brain natriuretic peptide and C-reactive protein for risk stratification in stable and unstable coronary artery disease: results from the AtheroGene study. Eur Heart J,2005,26:241-249.
  • 9Tommasi S, Carluccio E, Bentivoglio M, et al. C-reactive protein as a marker for cardiac ischemic events in the year after a first, uncomplicated myocardial infarction. Am J Cardiol, 1999,83 : 1595-1599.
  • 10Mega JL, Morrow DA, De Lemos JA, et al. B-type natfiuretic peptide at presentation and prognosis in patients with ST-segment elevation myocardial infarction : an ENTIRE-TIMI-23 substudy. J Am Coll Cardiol, 2004,44:335-339.

共引文献84

同被引文献75

引证文献9

二级引证文献61

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部